294 related articles for article (PubMed ID: 26723018)
1. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
[TBL] [Abstract][Full Text] [Related]
2. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
[TBL] [Abstract][Full Text] [Related]
3. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
5. Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy.
Sigaloff KC; Kayiwa J; Musiime V; Calis JC; Kaudha E; Mukuye A; Matama C; Nankya I; Nakatudde L; Dekker JT; Hamers RL; Mugyenyi P; Rinke De Wit TF; Kityo C
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):925-30. PubMed ID: 23517497
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children.
Musiime V; Kaudha E; Kayiwa J; Mirembe G; Odera M; Kizito H; Nankya I; Ssali F; Kityo C; Colebunders R; Mugyenyi P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):449-55. PubMed ID: 23308370
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
[TBL] [Abstract][Full Text] [Related]
9. Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis.
Jordan MR; Penazzato M; Cournil A; Vubil A; Jani I; Hunt G; Carmona S; Maphalala G; Mthethwa N; Watera C; Kaleebu P; Musanhu CC; Mtapuri-Zinyowera S; Dzangare J; Peeters M; Yang C; Parkin N; Bertagnolio S
Clin Infect Dis; 2017 Nov; 65(12):2018-2025. PubMed ID: 29020335
[TBL] [Abstract][Full Text] [Related]
10. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.
Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS
J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020
[TBL] [Abstract][Full Text] [Related]
11. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
[TBL] [Abstract][Full Text] [Related]
12. Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.
Budayanti NS; Merati TP; Bela B; Mahardika GN
Curr HIV Res; 2018; 16(5):374-382. PubMed ID: 30714528
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia.
Getaneh Y; He Q; Rashid A; Kassa D; Kang L; Yi F; Liao L; Shao Y
J Glob Antimicrob Resist; 2022 Sep; 30():418-427. PubMed ID: 35917929
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
[TBL] [Abstract][Full Text] [Related]
15. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS;
Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695
[TBL] [Abstract][Full Text] [Related]
17. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
[TBL] [Abstract][Full Text] [Related]
18. Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
Kaleebu P; Kirungi W; Watera C; Asio J; Lyagoba F; Lutalo T; Kapaata AA; Nanyonga F; Parry CM; Magambo B; Nazziwa J; Nannyonjo M; Hughes P; Hladik W; Ruberantwari A; Namuwenge N; Musinguzi J; Downing R; Katongole-Mbidde E;
PLoS One; 2015; 10(12):e0145536. PubMed ID: 26700639
[TBL] [Abstract][Full Text] [Related]
19. Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
Boerma RS; Sigaloff KC; Akanmu AS; Inzaule S; Boele van Hensbroek M; Rinke de Wit TF; Calis JC
J Antimicrob Chemother; 2017 Feb; 72(2):365-371. PubMed ID: 27999070
[TBL] [Abstract][Full Text] [Related]
20. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
